Please enable Javascript
Alicia Morgans, MD, MPH
Alicia Morgans, MD, MPH, of Dana-Farber Cancer Institute
Articles by Alicia Morgans, MD, MPH
Human First, Patient Second: Rethinking Cancer Care Systems
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel concludes with a candid discussion about the most urgent changes that could improve cancer care today.
View More
Proactive, Not Reactive: Introducing Palliative Care Without Fear
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel explores the importance of introducing palliative care discussions earlier in the treatment journey.
View More
The Price of Pills and the Weight of Words: Addressing Financial Barriers
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel explores the overlooked burden of financial toxicity and proactively raising the topic with patients.
View More
Between the Lines: Listening, Trust, and the Real-Life Cost of Cancer
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel explores how clinicians can build trust with patients from diverse backgrounds and ensure care is patient-centered.
View More
Trials and Trust: Offering Options Without Eroding Confidence
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel explores how clinicians can introduce clinical trial options while maintaining trust in the face of uncertainty.
View More
Beyond the Diagnosis: Humanizing the First Oncology Visit
Christopher Wallis, MD, PhD, FRCSC
Prostate Cancer
|
June 24, 2025
The panel explores the emotional weight of a cancer diagnosis and the importance of empathetic communication.
View More
ARAMIS Follow-Up: PSA Levels, Radiological Progression in nmCRPC
Alicia Morgans, MD, MPH
CRPC
|
June 12, 2024
Drs. Morgans, Wallis dissect the association between PSA level of < 0.2 ng/mL and risk of radiological progression in ...
View More
;